Viracta Therapeutics, Inc.
SEC CIK 1061027 · VIRX · last insider filing 2024-11-27
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Royston Ivor | Director · CEO & President | filed 2021 - 2024 |
| Pomerantz Roger | Director | filed 2021 - 2024 |
| Darcy Thomas E | Director | filed 2021 - 2024 |
| Simon Barry J. | Director | filed 2021 - 2024 |
| Barlow Jane F | Director | filed 2021 - 2024 |
| Murphy Samuel Lafayette | Director | filed 2021 - 2024 |
| Rubino Stephen | Director | filed 2021 - 2024 |
| Borellini Flavia | Director | filed 2021 - 2024 |
| Chung Jane | Director | filed 2022 - 2024 |
| Rothera Mark | Director · President and CEO | filed 2022 - 2024 |
| Onetto Nicole | Director | filed 2019 - 2022 |
| Huang Michael | Director | filed 2021 - 2022 |
| Roshwalb Gur | Director | filed 2021 - 2021 |
| Stump David C | Director | filed 2006 - 2020 |
| Young James W | Director · Executive Chairman | filed 2006 - 2020 |
| Ketchum Steven B | Director · Sr. Vice President, R & D | filed 2008 - 2020 |
| Wolff Henry Ward | Director | filed 2018 - 2020 |
| Pearce Homer L | Director | filed 2006 - 2020 |
| Misfeldt Dayton | Director · See Remarks | filed 2009 - 2020 |
| Carchedi Steve | Director | filed 2013 - 2020 |
| Swisher Daniel N JR | Director · President and CEO | filed 2006 - 2017 |
| Parker Geoffrey M. | Director | filed 2016 - 2017 |
| Fust Matthew | Director | filed 2006 - 2016 |
| Kim Helen Susan | Director | filed 2009 - 2015 |
| Hurwitz Edward | Director | filed 2009 - 2013 |
| Evnin Anthony B | Director | filed 2006 - 2009 |
| Goldby Steven D | Director | filed 2006 - 2008 |
| Leff Jonathan S | Director | filed 2006 - 2008 |
| Fodor Stephen P A | Director | filed 2006 - 2008 |
| Wells James A | Director | filed 2006 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Faerm Michael E. | Chief Financial Officer | filed 2024 - 2024 |
| Burcar Melody | Senior VP, Finance | filed 2024 - 2024 |
| Chevallard Daniel R. | Chief Executive Officer | filed 2021 - 2024 |
| Cohen Darrel P. | Chief Medical Officer | filed 2023 - 2024 |
| Rojkjaer Lisa | Chief Medical Officer | filed 2021 - 2023 |
| Hyare Parvinder S | See Remarks | filed 2021 - 2021 |
| Gullotta Tina | VP, Finance | filed 2020 - 2020 |
| Quinn William P. | See Remarks | filed 2017 - 2020 |
| Fox Judith A. | See Remarks | filed 2019 - 2020 |
| Bjerkholt Eric | Sr. VP, Corp. Dev. & Finance | filed 2006 - 2016 |
| Craig Adam R | EVP, Development & CMO | filed 2012 - 2015 |
| Depinto Joseph I | EVP, CCO | filed 2014 - 2014 |
| Pierce Valerie L | Sr. VP, GC and Corp. Sect. | filed 2007 - 2008 |
| Adelman Daniel C MD | Sr. VP, Development and CMO | filed 2006 - 2007 |
| Mcdowell Robert Scott | Vice President, Research | filed 2007 - 2007 |
| Winter Daryl B | SVP of I.P./Corp. Secretary | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.